Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 65
Filter
1.
Disabil Rehabil ; 43(19): 2720-2728, 2021 09.
Article in English | MEDLINE | ID: mdl-31967909

ABSTRACT

PURPOSE: Earthquake survivors whose physical injuries result in disability may be at increased risk for prolonged and severe post-traumatic stress disorder. We estimated the prevalence of post-traumatic stress disorder, functional limitations, and environmental barriers in 289 survivors with disabilities induced by the 2008 Wenchuan earthquake eight years after the disaster. We also investigated the relationship of post-traumatic stress disorder symptom severity with function, considering a mediating role of environmental barriers. METHODS: Post-traumatic stress disorder was measured with post-traumatic stress disorder checklist-civilian version. Physical and mental functioning was assessed with Medical Outcomes Short Form-36 and perceived environmental barriers were evaluated with Nottwil Environmental Factors Inventory-Short Form. Path analysis was employed to examine the relationship of exposures, post-traumatic stress disorder symptom severity, environmental barriers, and physical and mental function. RESULTS: Prevalence of probable post-traumatic stress disorder was 18.68% (95% CI: 14.19-23.18%). Earthquake survivors with lower physical and mental functioning perceived more environmental barriers, and those who perceived more barriers demonstrated more severe post-traumatic stress disorder symptoms, confirming a mediating role of environmental barriers. CONCLUSIONS: Long-term community-based health services for earthquake survivors with disabilities should combine both mental and physical rehabilitation and focus on creating disability-inclusive environments.Implications for rehabilitationEarthquake survivors whose physical injuries result in permanent disability may experience two different types of psychological trauma. The first originates from the initial psychological impact of the disaster and their injuries and the second arises from the added difficulty of coping with environmental barriers given the limitations imposed by their impairments.Even years after the disaster, prevalence of post-traumatic stress disorder is likely high in earthquake survivors with acquired musculoskeletal or neurological impairments and needs to be considered in the rehabilitation process.Physical and mental functioning, as well as environmental barriers, are important intervention targets to reduce post-traumatic stress disorder symptoms.Long-term community-based health services for earthquake survivors with disabilities are needed that combine both mental health and physical rehabilitation components with advocating for disability-inclusive environments.


Subject(s)
Disabled Persons , Disasters , Earthquakes , Stress Disorders, Post-Traumatic , China/epidemiology , Humans , Risk Factors , Stress Disorders, Post-Traumatic/epidemiology , Survivors
2.
Aliment Pharmacol Ther ; 47(10): 1358-1366, 2018 05.
Article in English | MEDLINE | ID: mdl-29577349

ABSTRACT

BACKGROUND: Coeliac disease is a substantially underdiagnosed disorder, with clinical testing currently guided by case finding. AIM: To determine the presence of indications for diagnostic testing and frequency of clinical testing in undiagnosed coeliac disease. METHODS: This was a case-control study of adults without prior diagnosis of coeliac disease. Undiagnosed cases were identified through sequential serology, and unaffected age- and gender-matched controls were selected. Medical records were systematically reviewed for indications for and evidence of clinical testing. RESULTS: Of 47 557 adults, 408 cases of undiagnosed coeliac disease were identified. 408 serology negative matched controls were selected. Eight-matched pairs were excluded, leading to 800 included individuals (61% female; median age 44.2 years). The odds of any indication for clinical testing were similar among undiagnosed coeliac disease and controls (odds ratio (OR) 1.18; 95% CI: 0.85-1.63, P = 0.32). Most individual indications were not associated with serologic status. Exceptions to this include hypothyroidism, which was more likely in cases of undiagnosed coeliac disease, and dyspepsia and chronic diarrhoea, which were less likely. Cases of undiagnosed coeliac disease were more likely to develop osteoporosis (P = 0.005), dermatitis herpetiformis (P = 0.006), chronic fatigue (P = 0.033), thyroiditis (P = 0.003), autoimmune diseases (P = 0.008), and have a family member diagnosed with coeliac disease (P = 0.001). CONCLUSION: This study strongly suggests that current case finding is not effective in detecting undiagnosed coeliac disease. Individuals with undiagnosed coeliac disease were more likely than controls to develop indications for testing overtime. A more effective method for detection of coeliac disease is needed.


Subject(s)
Autoimmune Diseases/epidemiology , Celiac Disease/diagnosis , Diarrhea/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Humans , Male , Middle Aged , Odds Ratio , Osteoporosis/epidemiology , United States , Young Adult
3.
Article in English | MEDLINE | ID: mdl-28596909

ABSTRACT

BACKGROUND: In low- and middle-income countries, mental health training often includes sending few generalist clinicians to specialist-led programs for several weeks. Our objective is to develop and test a video-assisted training model addressing the shortcomings of traditional programs that affect scalability: failing to train all clinicians, disrupting clinical services, and depending on specialists. METHODS: We implemented the program -video lectures and on-site skills training- for all clinicians at a rural Nepali hospital. We used Wilcoxon signed-rank tests to evaluate pre- and post-test change in knowledge (diagnostic criteria, differential diagnosis, and appropriate treatment). We used a series of 'Yes' or 'No' questions to assess attitudes about mental illness, and utilized exact McNemar's test to analyze the proportions of participants who held a specific belief before and after the training. We assessed acceptability and feasibility through key informant interviews and structured feedback. RESULTS: For each topic except depression, there was a statistically significant increase (Δ) in median scores on knowledge questionnaires: Acute Stress Reaction (Δ = 20, p = 0.03), Depression (Δ = 11, p = 0.12), Grief (Δ = 40, p < 0.01), Psychosis (Δ = 22, p = 0.01), and post-traumatic stress disorder (Δ = 20, p = 0.01). The training received high ratings; key informants shared examples and views about the training's positive impact and complementary nature of the program's components. CONCLUSION: Video lectures and on-site skills training can address the limitations of a conventional training model while being acceptable, feasible, and impactful toward improving knowledge and attitudes of the participants.

4.
Aliment Pharmacol Ther ; 45(5): 643-652, 2017 03.
Article in English | MEDLINE | ID: mdl-28052442

ABSTRACT

BACKGROUND: Therapy for coeliac disease (CD) mainly relies on following a gluten-free diet (GFD); however, a serum marker for gluten intake has yet to be established. AIM: To evaluate the utility of alkylresorcinol concentrations for detecting gluten intake in studies of human and mouse. METHODS: Alkylresorcinol concentrations were compared among treated patients with coeliac disease (n = 34), untreated coeliac disease patients (n = 36) and controls (n = 33). Furthermore, seven additional coeliac disease patients whose serum samples were available at diagnosis and after GFD were evaluated. In mice studies, alkylresorcinol concentrations were compared in the serum of five mice fed a regular chow and 10 mice fed lifelong with a gluten-free chow. In addition, the effect of adding gluten on changes of alkylresorcinol concentrations was also evaluated. RESULTS: Total alkylresorcinol concentrations were significantly lower in treated with coeliac disease [median (IQR), 3 (2-8) nmol/L], compared to untreated patients [median (IQR), 32 (11-74) nmol/L; P < 0.0001] or healthy controls [median (IQR), 54 (23-112) nmol/L; P < 0.0001]. Moreover, alkylresorcinol concentrations in coeliac disease patients significantly decreased after introduction of a GFD (median, 34 nmol/L at diagnosis vs. 5 nmol/L after GFD, P = 0.02). In the mice, median (IQR) total alkylresorcinol concentrations in serum samples of mice fed lifelong with a gluten-free chow was 1.8 (1.6-2.3) nmol/L, which was further significantly increased to 16 (11-22) nmol/L after 8 days of feeding with the gluten-free chow that had gluten added to it. (P = 0.008). CONCLUSION: Serum alkylresorcinol concentrations could be a useful marker for dietary gluten in coeliac disease.


Subject(s)
Celiac Disease/diet therapy , Diet, Gluten-Free , Glutens/administration & dosage , Resorcinols/blood , Adult , Animals , Biomarkers/metabolism , Case-Control Studies , Female , Humans , Male , Mice , Mice, Transgenic , Middle Aged
5.
Aliment Pharmacol Ther ; 32(2): 261-9, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20384611

ABSTRACT

BACKGROUND: Despite increasing prevalence, the economic implications of coeliac disease are just emerging. AIMS: To assess the impact of coeliac disease diagnosis on healthcare costs and the incremental costs associated with coeliac disease. METHODS: Administrative data for a population-based cohort of coeliac disease cases and matched controls from Olmsted County, Minnesota were used to compare (i) direct medical costs 1 year pre- and post-coeliac disease diagnosis for 133 index cases and (ii) 4-year cumulative direct medical costs incurred by 153 index cases vs. 153 controls. Analyses exclude diagnostic-related and out-patient pharmaceutical costs. RESULTS: Average total costs were reduced by $1764 in the year following diagnosis (pre-diagnosis cost of $5023 vs. $3259; 95% CI of difference: $688 to $2993). Over a 4-year period, coeliac disease cases experienced higher out-patient costs (mean difference of $1457; P = 0.016) and higher total costs than controls (mean difference of $3964; P = 0.053). Excess average total costs were concentrated among males with coeliac disease ($14,191 vs. $4019 for male controls; 95% CI of difference: $2334 to $20,309). CONCLUSIONS: Coeliac disease-associated costs indicate a significant economic burden of disease, particularly for diseased males. Diagnosis and treatment of coeliac disease reduce medical costs of care suggesting an economic advantage to earlier detection and treatment.


Subject(s)
Celiac Disease/economics , Adult , Celiac Disease/epidemiology , Cost of Illness , Economics, Hospital , Female , Health Care Costs , Humans , Male , Middle Aged , Minnesota/epidemiology , Prevalence
6.
Glob Public Health ; 3(1): 26-38, 2008.
Article in English | MEDLINE | ID: mdl-19288357

ABSTRACT

This paper calls for an alternate approach to studying the aetiology of women's health conditions. Instead of the long-established disease-specific, compartmentalized approach, it recommends focusing on risk exposures that allows for the identification of multiple disease conditions that stem from the same risk factors. Identifying common risk factors and the related pathways to adverse health outcomes can lead to the development of interventions that would favourably affect more than one disease condition. The utility of such an approach is illustrated by a review of literature from across the globe on the association between gender inequity-related exposures and women's health (namely, three health conditions: sexually transmitted infections [STIs], including Human Immunodeficiency Virus [HIV], blindness, and depression; as well as two risk behaviours: eating disorders and tobacco use). The review demonstrates how women's health cannot be viewed independently from the larger social, economic, and political context in which women are situated. Promoting women's health necessitates more comprehensive approaches, such as gender-sensitization of other family members, and the development of more creative and flexible mechanisms of healthcare delivery, that acknowledge the gender inequity-related constraints that women face in their daily lives.


Subject(s)
Risk Factors , Women's Health , Female , Health Services Accessibility , Health Status Disparities , Humans , Male
7.
Aliment Pharmacol Ther ; 14(7): 869-78, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10886042

ABSTRACT

BACKGROUND: Alosetron, a 5-HT3-receptor antagonist, relieves abdominal pain and improves bowel function in non-constipated, female patients with irritable bowel syndrome. 5-HT3 antagonists delay colonic transit, increase colonic compliance, and increase small intestinal water absorption. AIM: To evaluate the effects of alosetron on gastrointestinal and colonic transit, rectal compliance and rectal sensation in irritable bowel syndrome. METHODS: A double-blind, placebo-controlled, two-dose study of alosetron was performed in 25 non-constipated irritable bowel syndrome patients, with paired studies before and after 4 weeks of treatment with placebo (n=5), 1 mg alosetron (n=10) or 4 mg (n=10) alosetron b.d. Gastrointestinal and colonic transit were measured by scintigraphy. Rectal compliance and sensation were assessed by rectal balloon distention with a barostat. RESULTS: There was a trend (P=0.06) for 1 mg alosetron to increase rectal compliance (median pressure at half maximum volume 11 mmHg after alosetron vs. 15.6 mmHg before alosetron). The 1 mg b.d. alosetron dose non-significantly retarded proximal colonic transit. Alosetron and placebo reduced sensory scores relative to baseline values; none of the changes induced by alosetron was significant relative to placebo. CONCLUSIONS: Alosetron had no significant effect on gastrointestinal transit or rectal sensory and motor mechanisms in non-constipated irritable bowel syndrome patients in this study. Alosetron's effects on colonic sensorimotor function and central sensory mechanisms deserve further evaluation.


Subject(s)
Carbolines/therapeutic use , Colonic Diseases, Functional/drug therapy , Gastrointestinal Transit/drug effects , Adult , Aged , Carbolines/adverse effects , Carbolines/pharmacology , Colonic Diseases, Functional/physiopathology , Double-Blind Method , Female , Humans , Male , Middle Aged , Psychomotor Performance/drug effects , Rectum/drug effects , Rectum/physiology , Serotonin Antagonists/adverse effects , Serotonin Antagonists/pharmacology , Serotonin Antagonists/therapeutic use
8.
J Med Chem ; 42(9): 1537-45, 1999 May 06.
Article in English | MEDLINE | ID: mdl-10229624

ABSTRACT

Comparative molecular field analysis (CoMFA), a 3-D QSAR technique, is widely used to correlate biological activity with observed differences in steric and electrostatic fields. In this study, CoMFA was employed to generate a model, based upon 14 structurally diverse 5-phenylhydantoin analogues, to delineate structural and electrostatic features important for enhanced sodium channel binding. Correlation by partial least squares (PLS) analysis of in vitro sodium channel binding activity (expressed as log IC50) and the CoMFA descriptor column generated a final non-cross-validated model with R2 = 0.988 for the training set. The final CoMFA model explained the data better than a simpler correlation with log P (R2 = 0.801) for the same training set. The CoMFA steric and electrostatic maps described two general features that result in enhanced binding to the sodium channel. These include a preferred 5-phenyl ring orientation and a favorable steric effect resulting from the C5-alkyl chain. This model was then utilized to accurately predict literature sodium channel activities for hydantoins 14-20, which were not included in the training set. Finally the hydantoin CoMFA model was used to design the structurally novel alpha-hydroxy-alpha-phenylamide 21. Synthesis and subsequent sodium channel evaluation of compound 21 (predicted IC50 = 9 microM, actual IC50 = 9 microM), a good binder to the sodium channel, established that the intact hydantion ring is not necessary for efficient binding to this site. Thus alpha-hydroxy-alpha-phenylamides may represent a new class of ligands that bind with increased potency to the sodium channel.


Subject(s)
Amides/chemical synthesis , Anticonvulsants/metabolism , Hydantoins/metabolism , Neurons/metabolism , Sodium Channels/metabolism , Amides/chemistry , Amides/pharmacology , Animals , Cerebral Cortex/metabolism , Cerebral Cortex/ultrastructure , Hydantoins/chemistry , Ion Channel Gating , Least-Squares Analysis , Ligands , Models, Molecular , Molecular Conformation , Rats , Structure-Activity Relationship , Synaptosomes/metabolism
9.
Arthritis Rheum ; 40(11): 1992-7, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9365088

ABSTRACT

OBJECTIVE: To assess the frequency and characteristics of hilar and mediastinal involvement in patients with Wegener's granulomatosis (WG). METHODS: A patient with WG presented with the unusual finding of a mediastinal mass, prompting a comprehensive review of 302 patient records from 2 WG registries to obtain evidence of hilar adenopathy or mediastinal masses. Clinic progress notes and findings of chest imaging studies (routine imaging and computed tomography) were reviewed for the presence of hilar lymphadenopathy, mediastinal masses, or mediastinal lymphadenopathy. All radiographs and surgical pathology specimens from these lesions were reviewed. RESULTS: Six examples of mediastinal or hilar involvement (2.0%) were identified among 302 patients with WG. Three of these 6 patients had mediastinal masses. One patient with a mediastinal mass also had mediastinal lymphadenopathy. Two of the patients with mediastinal masses had lung parenchymal lesions. The remaining 3 patients had enlarged hilar lymph nodes in addition to pulmonary parenchymal lesions. All of the patients were treated with corticosteroids and cytotoxic drugs. Followup information was available on all patients. Two patients died. In the remaining 4 patients, the mediastinal mass or hilar lymphadenopathy decreased in size or resolved after 2 months of immunosuppressive therapy. CONCLUSION: In the past, hilar adenopathy and/or mediastinal mass have been considered unlikely features of WG, and their presence has prompted consideration of an alternative diagnosis. Although this caution remains valuable, the present retrospective review of data from 2 large WG registries illustrates that such findings may rarely be a part of the spectrum of WG chest disease. Because these findings are uncommon, they necessitate consideration of a primary or concurrent infection or malignancy in the diagnostic evaluation.


Subject(s)
Granulomatosis with Polyangiitis/complications , Lymphatic Diseases/epidemiology , Mediastinal Diseases/epidemiology , Adult , Aged , Cohort Studies , Female , Humans , Lymphatic Diseases/etiology , Male , Mediastinal Diseases/etiology , Middle Aged , Prevalence , Retrospective Studies , Time Factors , Treatment Outcome
10.
Ment Retard ; 35(2): 124-30, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9131872

ABSTRACT

Self-injurious behavior (SIB) is common among people with severe mental retardation who may also have multiple complex medical problems coupled with communication difficulties. This combination of factors sometimes makes it difficult to obtain accurate and detailed medical histories. In this exploratory descriptive study of 25 patients with SIB, 28% had previously undiagnosed medical conditions that could be expected to cause pain or discomfort. Six of the 7 patients experienced decreased SIB with treatment of their medical conditions. In patients with SIB, impaired communication skills, and complex medical histories, medical conditions that may be associated with pain or discomfort must be a consideration in determining the etiology of the SIB.


Subject(s)
Intellectual Disability/complications , Pain/etiology , Self-Injurious Behavior/etiology , Adolescent , Adult , Behavior Therapy , Child , Child, Preschool , Comorbidity , Diagnosis, Differential , Female , Gastrointestinal Diseases/complications , Gastrointestinal Diseases/psychology , Gastrointestinal Diseases/therapy , Humans , Intellectual Disability/psychology , Male , Pain/psychology , Pain Management , Patient Admission , Patient Care Team , Retrospective Studies , Self-Injurious Behavior/psychology , Self-Injurious Behavior/therapy
11.
Toxicol Appl Pharmacol ; 143(1): 37-46, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9073590

ABSTRACT

Following a formulation change, a leather conditioner was involved in a 1992 nationwide outbreak of respiratory illness. We investigated the composition and toxicity of the conditioner produced before (previous product) and after (new product) the disease outbreak. The new product induced tachypnea, pulmonary edema, pulmonary hemorrhage, and sporadic deaths in exposed guinea pigs and rats. Ultrastructurally, these changes were associate with direct pulmonary cytotoxicity characterized by necrosis of alveolar type I cells and alveolar septal interstitial edema. Chemical analyses suggested major alterations in the fluorohydrocarbon constituents in the new formulation of the leather conditioner. While these alterations could not be specifically identified, they appeared to include changes from fluoralkanes to fluoroalkenes, fluorophenyl, and/or fluoroalcohol compounds. Changes in solvent composition were consistent with traces of 2-butoxyethanol and isomers of dipropylene glycol methyl ether, and additional C10-C12 alkanes. In this study, we demonstrated the toxicity of the new product in laboratory animals. Some of the altered constituents of the new product have been identified and are potential candidates for additional investigations to identify specific etiologic agents.


Subject(s)
Acetates/toxicity , Ethylene Glycols/toxicity , Fluorocarbons/toxicity , Lung Diseases/chemically induced , Propane/toxicity , Propylene Glycols/toxicity , Solvents/toxicity , Aerosols , Animals , Bronchoalveolar Lavage Fluid/cytology , Epithelium/ultrastructure , Gap Junctions/ultrastructure , Guinea Pigs , Hemorrhage/chemically induced , Lung/drug effects , Lung/pathology , Lung Diseases/pathology , Male , Microscopy, Electron , Necrosis , Pulmonary Alveoli/ultrastructure , Rats , Rats, Sprague-Dawley , Specific Pathogen-Free Organisms , Tanning
13.
Neurology ; 47(5): 1153-7, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8909421

ABSTRACT

We monitored 56 patients with chronic progressive multiple sclerosis (MS) who participated in a clinical trial of weekly, low-dose oral methotrexate with annual gadolinium-enhanced MRIs of the brain (Gd + MRI). Not of these patients had clinical exacerbations during the 8 months preceding study entry. We also monitored 35 of the patients with serial Gd + MRIs every 6 weeks for 6 months. We observed a treatment effect, measured by absolute change in T2-weighted total lesion area (T2W-TLA), in the cohort that completed 6-week scans. We found change in T2W-TLA in this cohort to be significantly related to sustained change in performance on the nine-hold peg test but not to sustained change on the Expanded Disability Status Scale. Gadolinium enhancement of lesions on 6-week and annual scans was uncommon. Prestudy exacerbation frequency appears to be an important consideration in designing future clinical trials in patients with secondary and primary progressive MS.


Subject(s)
Methotrexate/administration & dosage , Multiple Sclerosis/drug therapy , Multiple Sclerosis/pathology , Administration, Oral , Adult , Double-Blind Method , Humans , Magnetic Resonance Imaging , Time Factors
14.
AJNR Am J Neuroradiol ; 17(3): 570-2, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8881256

ABSTRACT

Extraosseous multiple myeloma involving the larynx is rare. We describe a patient with multiple myeloma and a plasmacytoma involving the thyroid cartilage. Ossification of the thyroid cartilage with formation of a marrow space could explain the occurrence of multiple myeloma in this unusual location.


Subject(s)
Cartilage/diagnostic imaging , Multiple Myeloma/diagnostic imaging , Thyroid Neoplasms/diagnostic imaging , Tomography, X-Ray Computed , Hoarseness/etiology , Humans , Male , Middle Aged , Multiple Myeloma/complications , Thyroid Neoplasms/complications
15.
Gastroenterology ; 110(2): 405-10, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8566586

ABSTRACT

BACKGROUND & AIMS: Fat and complex carbohydrates in the distal bowel activate "brakes" inhibiting upper gut motility. The hypothesis of this study was that rapid transit carcinoid diarrhea in association with steatorrhea results in impairment of gastric emptying. METHODS: Fifteen patients with carcinoid diarrhea without prior gastrointestinal resection or whose small bowel resection was limited to < 100 cm of ileum were studied. Gastrointestinal transit was measured scintigraphically with a standardized meal. Percentage of ingested fat excretion was calculated. RESULTS: Mean length of small bowel resected was 33 cm, and mean 24-hour urine 5-hydroxyindoleacetic acid was 120 mg. Fourteen patients had increased daily stool weights, and 10 had increased stool fat excretion (mean, 13%). Transit was accelerated in the small bowel in 14 and in the colon in all patients. The lag time for gastric emptying was prolonged in 2 patients who had no previous resection. Gastric emptying rate was accelerated in 5, normal in 7, and delayed in 3 patients. CONCLUSIONS: Ileal and colonic brakes do not seem to delay gastric emptying in patients with carcinoid diarrhea associated with rapid transit and mild to moderate steatorrhea.


Subject(s)
Diarrhea/physiopathology , Dietary Fats/pharmacokinetics , Gastrointestinal Transit , Intestinal Absorption , Malignant Carcinoid Syndrome/physiopathology , Aged , Aged, 80 and over , Celiac Disease/etiology , Colon/physiopathology , Diarrhea/etiology , Diarrhea/metabolism , Female , Gastric Emptying , Humans , Hydroxyindoleacetic Acid/urine , Intestine, Small/physiopathology , Male , Malignant Carcinoid Syndrome/complications , Malignant Carcinoid Syndrome/metabolism , Middle Aged
16.
Am J Card Imaging ; 10(1): 1-13, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8680128

ABSTRACT

Along with hypertrophy of the left ventricle (LV), hypertrophic cardiomyopathy (HC) is characterized by LV outflow tract (LVOT) obstruction, partly from systolic anterior motion (SAM) of the anterior mitral leaflet; if obstruction is significant, excision of excess subaortic septal myocardium may be indicated. In this study, the ability of computed tomography magnetic resonance imaging (Cine MRI) to provide information about LVOT obstruction was assessed in a series of 37 HC cases undergoing evaluation, including echocardiography (0 to 14 days before), for possible septal myectomy; in 4 cases, Cine MRI was used postsurgically (5 to 25 months after). Blinded to echocardiography results, 3 reviewers analyzed by consensus the Cine-MRI LVOT-long-axis image-loops for SAM grade (none, mild, severe) and "aorta:LVOT signal ratio" (intensity in descending aorta/intensity in LVOT at maximum systolic-flow disturbance). Resting LVOT flow velocities were separately determined using Doppler analysis, permitting differentiation between insignificant (< 30 mm Hg) and significant (< or = 30 mm Hg) gradients. With echocardiography, significant resting obstruction was found in 62% of cases, including 92% treated surgically. A significant association between SAM grade and obstruction was found; all cases with a SAM grade of none had insignificant ([-] predictive value: 100%) and most with a severe grade had significant ([+] predictive value: 78%) obstruction. Signal ratio in the absence of a significant gradient was significantly lower than in its presence; a significant linear relationship between aorta:LVOT signal ratio and resting gradient was found: LVOT gradient = ([2.9] x [signal ratio]) + 22.8. SAM grade did not contribute significantly in obstruction categorization when signal ratio was known. In all cases studied after surgery, SAM grade had decreased from severe to insignificant levels and aorta:LVOT signal ratio had been significantly reduced. Insights into the dynamic nature of the LVOT in HC patients can be provided by Cine MRI, either during their evaluation for surgery or after their septal myectomy.


Subject(s)
Cardiomyopathy, Hypertrophic/complications , Magnetic Resonance Imaging, Cine , Ventricular Outflow Obstruction/diagnosis , Cardiomyopathy, Hypertrophic/diagnosis , Cardiomyopathy, Hypertrophic/surgery , Echocardiography , Female , Humans , Male , Middle Aged , Postoperative Care , Predictive Value of Tests , Preoperative Care , Regression Analysis , Ventricular Outflow Obstruction/etiology , Ventricular Outflow Obstruction/surgery
17.
Ann Neurol ; 37(1): 30-40, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7818255

ABSTRACT

A randomized, double-blinded, placebo-controlled, clinical trial of low-dose, weekly, oral methotrexate was performed in 60 patients with clinically definite chronic progressive multiple sclerosis (MS) attending a referral-based outpatient MS clinic. Study patients were 21 to 60 years old with a disease duration of longer than 1 year. Patients' Expanded Disability Status Scale scores were 3.0 to 6.5 (ambulatory with moderate disability). Patients were first stratified by Expanded Disability Status Scale scores, 3.0 to 5.5 and 6.0 to 6.5, and then were randomized to receive methotrexate or placebo treatment. Treatment consisted of weekly, oral, low-dose (7.5 mg) methotrexate or identical placebo for 2 years, followed by observation for as long as 1 year. A composite outcome measurement instrument was used and consisted of (1) Expanded Disability Status Scale, (2) ambulation index, (3) Box and Block Test, and (4) 9-Hole Peg Test. Failure of therapy was indicated by a designated change that was sustained for more than 2 months in one or more components of this composite measure. Significantly less progression of impairment as measured by validated tests of upper-extremity function was observed in the methotrexate treatment group in the absence of clinically significant toxicity. We conclude that low-dose, weekly, oral methotrexate offers a new, relatively nontoxic treatment option for patients with chronic progressive MS.


Subject(s)
Methotrexate/administration & dosage , Multiple Sclerosis/drug therapy , Administration, Oral , Adult , Chronic Disease , Double-Blind Method , Female , Humans , Immunosuppression Therapy , Male , Methotrexate/adverse effects , Middle Aged , Treatment Failure , Treatment Outcome
18.
Electroencephalogr Clin Neurophysiol ; 92(6): 536-45, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7527772

ABSTRACT

Recent findings of missing or markedly attenuated P50 (or P1) auditory ERPs in Alzheimer's disease (AD) patients suggest this may be a useful diagnostic and/or prognostic marker of AD cholinergic deficits. Those studies used repetitive 1/sec clicks. Given P50's long recovery time, all but the first click in that paradigm was presented during the recovery of the P50 generation system from the response to the prior click. We studied 8 AD patients and 17 elderly controls using a paradigm incorporating 7-8 sec intervals between clicks, which allows examination of P50 generation separate from P50 recovery. With the long inter-click interval, we identified P50 responses in most AD patients and controls, and found no difference in P50 amplitude between groups. These results suggest that if there is a P50 deficit in AD patients, it is the result of the accumulative effect of repetitive stimulation, rather than a primary deficit in P50 generation.


Subject(s)
Alzheimer Disease/physiopathology , Brain/physiology , Evoked Potentials, Auditory/physiology , Acoustic Stimulation , Aged , Aged, 80 and over , Brain Mapping , Electroencephalography , Humans , Reaction Time/physiology
19.
Ann Neurol ; 36(1): 40-7, 1994 Jul.
Article in English | MEDLINE | ID: mdl-8024260

ABSTRACT

We used spin-echo magnetic resonance imaging and proton magnetic resonance spectroscopic imaging in 8 patients with probable Alzheimer's disease and in 10 age-matched elderly control subjects to assess the effects of Alzheimer's disease on the brain. On magnetic resonance images the patients showed significant ventricular enlargements relative to the control subjects. We measured the distribution and relative signal intensities of N-acetylaspartate (a putative neuronal marker), of choline residues representing lipid metabolites, and of creatine-containing metabolites in a large section of the centrum semiovale containing white and mesial gray matter. Throughout the white matter of the patients with Alzheimer's disease compared to elderly control subjects, N-acetylaspartate was decreased relative to choline (N-acetylaspartate-choline ratio) and creatine-containing metabolites (N-acetylaspartate-creatine ratio) with no changes in the choline-creatine ratio. The N-acetylaspartate-choline ratio was lower and choline-creatine higher in the mesial gray matter of AD patients relative to elderly controls. The posterior section of the centrum semiovale in the patients showed increased choline-creatine and choline-N-acetylaspartate ratios with the N-acetylaspartate-creatine ratio unchanged between the patients and control subjects. These spectroscopic findings give suggestive evidence of diffuse axonal injury and membrane alterations in gray and white matter of the centrum semiovale in patients with Alzheimer's disease.


Subject(s)
Alzheimer Disease/diagnosis , Brain/metabolism , Magnetic Resonance Spectroscopy , Aged , Aging/metabolism , Alzheimer Disease/metabolism , Aspartic Acid/analogs & derivatives , Aspartic Acid/metabolism , Axons/metabolism , Brain/anatomy & histology , Cerebral Cortex/metabolism , Cerebral Ventricles/anatomy & histology , Choline/metabolism , Creatine/metabolism , Female , Humans , Male , Middle Aged
20.
J Clin Pharmacol ; 33(12): 1149-64, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8126250

ABSTRACT

Ball-and-stick mechanical models, typically associated with chemists, have been helpful in understanding structural problems and the relationship between structure and biologic activity. With progress in computer speed, graphics performance, and software innovation, molecules of biological interest can be subjected to rigorous calculations. Computational chemistry and biology are rooted in the belief that theoretical physics can be used to calculate accurate molecular structures. Although in its infancy, computer-assisted molecular modeling is gaining attention and acceptability as an increasing number of researchers turn their attention toward rational molecular design. The trend to use theoretical methods can be traced to the greater availability of computer graphics work-stations, decreasing computer costs, faster central processing units, more robust algorithms, and "user-friendly" software codes. Every major pharmaceutical company has invested in these resources to reduce the time it takes to design and develop pharmaceutical agents. Because of the vast financial and manpower investments needed to introduce a single drug, medicinal chemists and pharmacologists are interested in understanding and predicting drug action at the molecular level. Although drug action is still poorly understood, molecular modeling should reduce some of the labor in the development of pharmaceutical agents.


Subject(s)
Models, Molecular , Pharmacology/instrumentation , Computer Graphics , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...